Evaluation issues in the swedish two-county trial of breast cancer screening: An historical review

Laszlo Tabar, Tony Hsiu Hsi Chen, Chen Yang Hsu, Wendy Yi Ying Wu, Amy Ming Fang Yen, Sam Li Sheng Chen, Sherry Yueh Hsia Chiu, Jean Ching Yuan Fann, Kerri Beckmann, Robert A. Smith, Stephen W. Duffy

研究成果: 雜誌貢獻回顧型文獻

6 引文 (Scopus)

摘要

Objectives: To summarize debate and research in the Swedish Two-County Trial of mammographic screening on key issues of trial design, endpoint evaluation, and overdiagnosis, and from these to infer promising directions for the future. Methods: A cluster-randomized controlled trial of the offer of breast cancer screening in Sweden, with a single screen of the control group at the end of the screening phase forms the setting for a historical review of investigations and debate on issues of design, analysis, and interpretation of results of the trial. Results: There has been considerable commentary on the closure screen of the control group, ascertainment of cause of death, and cluster randomization. The issues raised were researched in detail and the main questions answered in publications between 1989 and 2003. Overdiagnosis issues still remain, but methods of estimation taking full account of lead time and of non-screening influences on incidence (taking place mainly before 2005) suggest that it is a minor phenomenon. Conclusion: Despite resolution of issues relating to this trial in peer-reviewed publications dating from years, or even decades ago, issues that already have been addressed continue to be raised. We suggest that it would be more profitable to concentrate efforts on current research issues in breast cancer diagnosis, treatment, and prevention.
原文英語
頁(從 - 到)27-33
頁數7
期刊Journal of Medical Screening
24
發行號1
DOIs
出版狀態已發佈 - 2017

指紋

Early Detection of Cancer
Publications
Breast Neoplasms
Control Groups
Random Allocation
Research
Sweden
Cause of Death
Randomized Controlled Trials
Incidence
Medical Overuse
Direction compound

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

引用此文

Evaluation issues in the swedish two-county trial of breast cancer screening : An historical review. / Tabar, Laszlo; Chen, Tony Hsiu Hsi; Hsu, Chen Yang; Wu, Wendy Yi Ying; Yen, Amy Ming Fang; Chen, Sam Li Sheng; Chiu, Sherry Yueh Hsia; Fann, Jean Ching Yuan; Beckmann, Kerri; Smith, Robert A.; Duffy, Stephen W.

於: Journal of Medical Screening, 卷 24, 編號 1, 2017, p. 27-33.

研究成果: 雜誌貢獻回顧型文獻

Tabar, L, Chen, THH, Hsu, CY, Wu, WYY, Yen, AMF, Chen, SLS, Chiu, SYH, Fann, JCY, Beckmann, K, Smith, RA & Duffy, SW 2017, 'Evaluation issues in the swedish two-county trial of breast cancer screening: An historical review', Journal of Medical Screening, 卷 24, 編號 1, 頁 27-33. https://doi.org/10.1177/0969141316631375
Tabar, Laszlo ; Chen, Tony Hsiu Hsi ; Hsu, Chen Yang ; Wu, Wendy Yi Ying ; Yen, Amy Ming Fang ; Chen, Sam Li Sheng ; Chiu, Sherry Yueh Hsia ; Fann, Jean Ching Yuan ; Beckmann, Kerri ; Smith, Robert A. ; Duffy, Stephen W. / Evaluation issues in the swedish two-county trial of breast cancer screening : An historical review. 於: Journal of Medical Screening. 2017 ; 卷 24, 編號 1. 頁 27-33.
@article{6a048f478e8f47fe9d89e2d395fc2c17,
title = "Evaluation issues in the swedish two-county trial of breast cancer screening: An historical review",
abstract = "Objectives: To summarize debate and research in the Swedish Two-County Trial of mammographic screening on key issues of trial design, endpoint evaluation, and overdiagnosis, and from these to infer promising directions for the future. Methods: A cluster-randomized controlled trial of the offer of breast cancer screening in Sweden, with a single screen of the control group at the end of the screening phase forms the setting for a historical review of investigations and debate on issues of design, analysis, and interpretation of results of the trial. Results: There has been considerable commentary on the closure screen of the control group, ascertainment of cause of death, and cluster randomization. The issues raised were researched in detail and the main questions answered in publications between 1989 and 2003. Overdiagnosis issues still remain, but methods of estimation taking full account of lead time and of non-screening influences on incidence (taking place mainly before 2005) suggest that it is a minor phenomenon. Conclusion: Despite resolution of issues relating to this trial in peer-reviewed publications dating from years, or even decades ago, issues that already have been addressed continue to be raised. We suggest that it would be more profitable to concentrate efforts on current research issues in breast cancer diagnosis, treatment, and prevention.",
keywords = "Breast cancer screening, Mammography, Randomised trial",
author = "Laszlo Tabar and Chen, {Tony Hsiu Hsi} and Hsu, {Chen Yang} and Wu, {Wendy Yi Ying} and Yen, {Amy Ming Fang} and Chen, {Sam Li Sheng} and Chiu, {Sherry Yueh Hsia} and Fann, {Jean Ching Yuan} and Kerri Beckmann and Smith, {Robert A.} and Duffy, {Stephen W.}",
year = "2017",
doi = "10.1177/0969141316631375",
language = "English",
volume = "24",
pages = "27--33",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Evaluation issues in the swedish two-county trial of breast cancer screening

T2 - An historical review

AU - Tabar, Laszlo

AU - Chen, Tony Hsiu Hsi

AU - Hsu, Chen Yang

AU - Wu, Wendy Yi Ying

AU - Yen, Amy Ming Fang

AU - Chen, Sam Li Sheng

AU - Chiu, Sherry Yueh Hsia

AU - Fann, Jean Ching Yuan

AU - Beckmann, Kerri

AU - Smith, Robert A.

AU - Duffy, Stephen W.

PY - 2017

Y1 - 2017

N2 - Objectives: To summarize debate and research in the Swedish Two-County Trial of mammographic screening on key issues of trial design, endpoint evaluation, and overdiagnosis, and from these to infer promising directions for the future. Methods: A cluster-randomized controlled trial of the offer of breast cancer screening in Sweden, with a single screen of the control group at the end of the screening phase forms the setting for a historical review of investigations and debate on issues of design, analysis, and interpretation of results of the trial. Results: There has been considerable commentary on the closure screen of the control group, ascertainment of cause of death, and cluster randomization. The issues raised were researched in detail and the main questions answered in publications between 1989 and 2003. Overdiagnosis issues still remain, but methods of estimation taking full account of lead time and of non-screening influences on incidence (taking place mainly before 2005) suggest that it is a minor phenomenon. Conclusion: Despite resolution of issues relating to this trial in peer-reviewed publications dating from years, or even decades ago, issues that already have been addressed continue to be raised. We suggest that it would be more profitable to concentrate efforts on current research issues in breast cancer diagnosis, treatment, and prevention.

AB - Objectives: To summarize debate and research in the Swedish Two-County Trial of mammographic screening on key issues of trial design, endpoint evaluation, and overdiagnosis, and from these to infer promising directions for the future. Methods: A cluster-randomized controlled trial of the offer of breast cancer screening in Sweden, with a single screen of the control group at the end of the screening phase forms the setting for a historical review of investigations and debate on issues of design, analysis, and interpretation of results of the trial. Results: There has been considerable commentary on the closure screen of the control group, ascertainment of cause of death, and cluster randomization. The issues raised were researched in detail and the main questions answered in publications between 1989 and 2003. Overdiagnosis issues still remain, but methods of estimation taking full account of lead time and of non-screening influences on incidence (taking place mainly before 2005) suggest that it is a minor phenomenon. Conclusion: Despite resolution of issues relating to this trial in peer-reviewed publications dating from years, or even decades ago, issues that already have been addressed continue to be raised. We suggest that it would be more profitable to concentrate efforts on current research issues in breast cancer diagnosis, treatment, and prevention.

KW - Breast cancer screening

KW - Mammography

KW - Randomised trial

UR - http://www.scopus.com/inward/record.url?scp=85016230328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016230328&partnerID=8YFLogxK

U2 - 10.1177/0969141316631375

DO - 10.1177/0969141316631375

M3 - Review article

C2 - 27098311

AN - SCOPUS:85016230328

VL - 24

SP - 27

EP - 33

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

IS - 1

ER -